Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

6 results
Display

Laboratory Indicators for Convalescence in SARS-CoV-2 Positive Cases with High Ct Value

Na R, Park K, Sung H, Kim MN

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
EUCAST v.12.0 Review Focused on Changes

Song SA

Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint tables are commonly used as guidelines for the interpretation of antimicrobial susceptibility testing results. These...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The First Case of Bacteremia Caused by Bordetella hinzii in Korea

Yu J, Kim S, Hur KH, Sung H, Kim MN

Bordetella hinzii is a nonfermenting, gram-negative rod and a rare opportunistic pathogen that can cause respiratory infections, bacteremia, and cholangitis. Here, we report the first case of bacteremia caused by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antimicrobial Susceptibility Patterns and Clinical Characteristics of Corynebacterium striatum Cases from 2018 to 2021

Choi I, Lee Y

Background: Corynebacterium striatum is part of the normal flora of the skin, oral cavity, and intestine. However, it can be a pathogen causing endocarditis, pneumonia, arthritis, and meningitis occasionally. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
On-Field Evaluation of Exdia COVID-19 Antigen Point-of-Care Testing in the Emergency Department During the COVID-19 Pandemic

Yoo IY, Lee GD, Chae H, Youn CS, Oh EJ, Park YJ

Background: We evaluated the diagnostic performance of the Exdia COVID-19 antigen test (Exdia Ag; Precision Biosensor Inc., Korea) as a point-of-care (POC) test performed in the emergency department (ED) for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antibody Detection in Healthcare Workers after Vaccination with Two Doses of the BNT162b2 or ChAdOx1 Vaccine

Roh KH, Choi H, Choi H, Yoon M, Yoo J, Park Y

Background: Due to the COVID-19 pandemic, from 2020, many pharmaceutical companies have developed vaccines. To determine the efficacy of AstraZeneca's and Pfizer's vaccines, which were the first and second vaccines...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr